DSpace

Digital.CSIC > Biología y Biomedicina > Instituto de Biomedicina de Valencia (IBV) > (IBV) Artículos >

Share

EndNote

Impact

Open Access item In vivo discovery of a peptide that prevents CUG-RNA hairpin formation and reverses RNA toxicity in myotonic dystrophy models

Authors:García-López, Amparo
Llamusí, Beatriz
Orzáez, Mar
Pérez-Payá, Enrique
Artero, Ruben D.
Issue Date:19-Jul-2011
Publisher:National Academy of Sciences (U.S.)
Citation:Proceedings of the National Academy of Sciences of the USA 108(29):11866-11871 (2011)
Abstract:Myotonic dystrophy type 1 (DM1) is caused by the expansion of noncoding CTG repeats in the dystrophia myotonica-protein kinase gene. Mutant transcripts form CUG hairpins that sequester RNA-binding factors into nuclear foci, including Muscleblind-like-1 protein (MBNL1), which regulate alternative splicing and gene expression. To identify molecules that target toxic CUG transcripts in vivo, we performed a positional scanning combinatorial peptide library screen using a Drosophila model of DM1. The screen identified a D-amino acid hexapeptide (ABP1) that reduced CUG foci formation and suppressed CUG-induced lethality and muscle degeneration when administered orally. Transgenic expression of natural, L-amino acid ABP1 analogues reduced CUG-induced toxicity in fly eyes and muscles. Furthermore, ABP1 reversed muscle histopathology and splicing misregulation of MBNL1 targets in DM1 model mice. In vitro, ABP1 bound to CUG hairpins and induced a switch to a single-stranded conformation. Our findings demonstrate that ABP1 shows antimyotonic dystrophy activity by targeting the core of CUG toxicity
Description:6 pages, 5 figures. PMID:21730182[PubMed] PMCID: PMC3141925[Available on 2012/1/19]
Publisher version (URL):http://dx.doi.org/10.1073/pnas.1018213108
URI:http://hdl.handle.net/10261/41289
ISSN:0027-8424
E-ISSNmetadata.dc.identifier.doi = DOI:1091-6490
???metadata.dc.identifier.doi???:10.1073/pnas.1018213108
Appears in Collections:(IBV) Artículos

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.